Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...

Amgen plans to proceed with Phase 3 trials, initiating patients on a lower dosage that will gradually increase over an ...

Win Advisors Inc. recently acquired 3,241 shares of Amgen, investing roughly $1,010,000, as disclosed in their latest SEC ...

Amgen Inc. ( NASDAQ: AMGN) Special Call (IR Call) Conference June 23, 2025 5:30 PM ET Justin Claeys - Vice President of Investor Relations James Bradner - Executive Vice President of Research & ...

These funds have a long track record of returning far more than 10% per year. The post 2 market-beating ASX ETFs to buy with ...

Amgen shares are trading lower Monday afternoon. The company released full results from part one of its phase two study of ...

Amgen's late-stage weight-loss drug MariTide is getting ready to enter the final stages of testing as the company enrolls its ...

The lawmakers accuse Pfizer, Merck, J&J, AbbVie and Amgen of paying little to nothing in federal taxes despite generating ...

The U.S. Court of Appeals for the Third Circuit issued a precedential opinion in a case arising out of a somewhat obscure ...

Amgen Inc. closed 15.40% below its 52-week high of $346.85, which the company reached on July 25th.

WASHINGTON _ Despite recent efforts to remove or rename Confederate memorials, there are still more than 2,000 symbols in places across the country, according to a report released Thursday.